Guided Therapeutics (GTHP) Non-Current Debt (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly Non-Current Debt came in at $53000.0 in Q2 2026, up 51.43% year-over-year from $35000.0 in Q2 2025, and down 41.76% quarter-over-quarter from $91000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Non-Current Debt (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Non-Current Debt across 17 years of filings, most recently posting $53000.0 for Q2 2026.
- In Q2 2026, Non-Current Debt rose 51.43% year-over-year to $53000.0; the TTM figure through Jun 2026 stood at $53000.0 (up 51.43% YoY), while the FY2025 annual figure was $105000.0, up 123.4% from the prior year.
- Non-Current Debt came in at $53000.0 for Q2 2026 at Guided Therapeutics, down from $91000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $590000.0 in Q3 2022 to a low of $22770.0 in Q1 2023.
- Average Non-Current Debt over 5 years is $150450.4, with a median of $56569.0 recorded in 2022.
- The largest YoY upside for Non-Current Debt was 451.96% in 2023 against a maximum downside of 95.99% in 2023.
- Over 5 years, Non-Current Debt stood at $56569.0 in 2022, then jumped by 66.44% to $94152.0 in 2023, then tumbled by 50.08% to $47000.0 in 2024, then surged by 123.4% to $105000.0 in 2025, then tumbled by 49.52% to $53000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $53000.0 in Q2 2026, $91000.0 in Q1 2026, and $105000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | 53,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 83,162.00 |
| Mar 31, 2024 | 24,003.00 |
| Sep 30, 2023 | 94,152.00 |
| Jun 30, 2023 | 563,000.00 |
| Mar 31, 2023 | 22,770.00 |
| Dec 31, 2022 | 56,569.00 |
| Sep 30, 2022 | 590,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 568,000.00 |
| Dec 31, 2021 | 592,000.00 |
| Sep 30, 2021 | 787,000.00 |
| Jun 30, 2021 | 755,000.00 |